ClinicalTrials.Veeva

Menu

Pediatric Decentralization of ART in South Africa

Columbia University logo

Columbia University

Status

Completed

Conditions

HIV/AIDS

Treatments

Other: Tier.net
Other: Tracing questionnaire
Other: Data abstraction

Study type

Observational

Funder types

Other

Identifiers

NCT03049891
AAAO9854

Details and patient eligibility

About

The decentralization study will describe children taking antiretroviral therapy (ART) at a larger health facility in the Eastern Cape province of South Africa, between the years of 2004-2013. The study will be conducted at Dora Nginza Hospital (DNH). The study will measure how many children stay in care and how many die, as well as their health status. The study will also compare whether children do better if they stay in care a large hospitals or if they get health care at smaller clinics. A second part of the study will find children in the community who have stopped coming for health care and find out what happened to them and what their health status is.

Full description

The investigators propose to conduct a two part study which will include a retrospective cohort study to examine care outcomes among pediatric patients 0-14 years of age initiated on antiretroviral therapy (ART) in 2004-2013 at a larger peri-urban health facility in the Eastern Cape province of South Africa. The study will be conducted at Dora Nginza Hospital (DNH). The outcomes measured in the study will include retention and mortality, as well as virologic suppression rates for children initiated on ART. In addition to reporting outcomes for all children with available data, the study will compare outcomes for children retained in care at DNH (where they initiated ART) to those children who were referred out after initiation for routine follow-up at community health clinics and primary care clinics ("down referred"). A second part of the study will trace pediatric patients in the community who have been lost to follow-up (LTF) to ascertain their outcomes after they left care at the health facility.

Enrollment

1,583 patients

Sex

All

Ages

Under 14 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

ART Outcomes Study:

Inclusion Criteria:

  • HIV positive; less than 15 years of age; started ART at DNH between 2004 and 2013.

Exclusion Criteria:

  • Anyone not meeting inclusion criteria

Tracing Study:

Inclusion Criteria:

  • Legal caregiver (older than 18) a child who was included in the ART Outcomes Study that was found to be LTFU from DNH or from the down-referral facility.

Exclusion Criteria:

  • Guardians who cannot be confirmed as the legal caregiver of the child

Trial design

1,583 participants in 4 patient groups

Children down-referred from DNH
Description:
This group includes children who were transferred from DNH to a study facility. The investigators will first abstract data from the electronic data system 'Tier.net' for these children, which will tell us where they were down-referred. For children who were labeled as down-referred from DNH in Tier.net, data abstraction of the child's clinical data will be conducted at the down-referral site and from the National Health Laboratory Service (NHLS) data.
Treatment:
Other: Data abstraction
Other: Tier.net
Children LTF from DNH
Description:
This group includes children who began ART at DNH and were subsequently LTF. The investigators will first abstract data from the electronic data system 'Tier.net', which will classify them as LTF followed by examination of the the NHLS laboratory data to determine whether these children had received care at another facility since they were LTF.
Treatment:
Other: Data abstraction
Other: Tier.net
Caregivers of LTF
Description:
This group includes the caregivers of a subset of children in the 'LTF from DNH' and 'down-referred from DNH' groups. Among those children down-referred and LTF from DNH, the investigators will use their clinical and laboratory data to determine whether they are still receiving care or not. For children identified as LTF based on their abstracted data will be traced in order to contact their caregivers. If located, caregivers will be interviewed to ascertain if and why these children are no longer in care through a 'Tracing questionnaire'.
Treatment:
Other: Tracing questionnaire
DNH only
Description:
This group includes children who are still in care at DNH, died while in care at DNH, or were transferred to facilities from tier.net will not have any additional information collected other than what is recorded in the Tier.net database.
Treatment:
Other: Tier.net

Trial contacts and locations

15

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems